Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase. - Dewerchin, M; Vandamme, AM; Holvoet, P (Thromb Haemost, 1992)